neobookRx
DrugsLevel 4 LocalisationS2INJ · VACEML

Measles Vaccine, Live Attenuated

Measles vaccineLive attenuated vaccine

Indications

Registered South African indications:

  • Immunisation against measles

Cautions

Contraindications

  • Hypersensitivity to the active ingredient or any of the excipients
  • Active or developing acute respiratory infection, including active untreated tuberculosis
  • Acute infectious diseases, leukaemia, severe anaemia, and other severe diseases of the blood system
  • Severe impairment of renal function and decompensated heart diseases
  • Measles vaccine should be avoided in other cell-mediated immune deficiency states
  • Known allergy to kanamycin sulphate and erythromycin

Measles vaccine may be used in children with known or suspected HIV infection, as there is no evidence to date of any increased rate of adverse reactions in symptomatic or asymptomatic HIV-infected children


Cautions

  • Pregnancy
  • Breastfeeding
  • Mild to moderate renal impairment
  • Thrombocytopenia
  • History of idiopathic thrombocytopenia purpura
  • Bleeding disorder

Adult dosage

Not established for use in adults

Paediatric dosage

Forms avail. in SA and covered in this monograph: inj

EPI Schedule 2016

Immunisation of children at 9-18 months of age

  • SC: 0.5ml

Not to be used in combination with other childhood vaccinations


DO NOT administer via IV or IM route

Special populations

Pregnancy

  • Caution; not recommended

Breastfeeding

  • Caution; not recommended  
  • There is limited experience with the Measles vaccine during breastfeeding
  • Studies have shown that breastfeeding postpartum women vaccinated with live attenuated rubella vaccines may secrete the virus in breast milk and transmit it to breastfed infants without evidence of any symptomatic disease
  • Only in the event the child is confirmed or suspected to be immunodeficient, risks and benefits of vaccinating the mother should be evaluated

Renal Impairment

  • Mild to moderate: Caution; no information available
  • Severe: Contraindicated

Hepatic Impairment

  • No dose adjustment recommended

Elderly

  • Not indicated for use in geriatric patients

Porphyria Information

Drugs in Sport

  • Permitted - No warnings

Adverse reactions

Central Nervous System Disorders

  • Febrile convulsion

Gastrointestinal Disorders

  • Diarrhoea
  • Nausea and vomiting
  • Abdominal pain

Immune, Blood and Lymphatic System Disorders

  • Adenopathy
  • Thrombocytopaenic purpura
  • Allergic reaction
  • Anaphylactic reaction
  • Anaphylactoid reactions

Sensory Disorders

  • Conjunctivitis 

Interactions

  • Immunoglobulins
  • Immunosuppressants
  • Corticosteroids

Monitoring

None routine

Mechanism of action

The live, attenuated measles vaccine stimulates the production of antibodies to the measles virus. 

Dosage forms

  • Injection
  • Vaccine

Formulation

Injection 0.5ml

  • Rouvax (Sanofi) originator
  • Measbio (Biovac)
  • Measles Vaccine Cipla (Cipla Medpro)

References

1. SAMF_12th Edition_Page 363 2. https://drive.google.com/drive/folders/14DoIooPuWgpJn_50PPNPmCbKyBW8jtT0 (04/2014_Sanofi_Rouvax) 3. https://drive.google.com/drive/folders/14DoIooPuWgpJn_50PPNPmCbKyBW8jtT0 (30/10/2016_Biovac_MeasBio) 4. SmPC: Priorix (GlaxoSmithKline UK) , Last updated on emc: 14 Jan 2020 , Downloaded 11/3/2020 [https://www.medicines.org.uk/emc/product/1159] 5.Clinical Pharmacologist - Dr. M Irhuma [https://trello.com/c/rMS5bjHg/321-list-of-hot-monographs] 6. http://porphyriadrugs.com/ (NAPOS) [Accessed on 18/2/2020] 7. PI - MeasBio (freeze-dried powder for reconstitution and injection), The Biovac Institute - Date of most recent revision: 13 July 2021 - Downloaded online 03 October 2024 [https://pi-pil-repository.sahpra.org.za/wp-content/uploads/2023/03/Measbio-Approved-pi-20-Oct-2021.pdf]

Brands & products

4 products · cached snapshot
Trade names (3)
  • Rouvax
  • MeasBio
  • Measles Vaccine Cipla

INJInjection· 3 products

from R157.05
ProductStrengthPackApplicantMin price
Measles Vaccine Cipla1000 ccid50/0.5ml1Cipla Medpro (Pty) LtdR157.05
Measles Vaccine Cipla1000 ccid50/0.5ml1Cipla Medpro (Pty) LtdR1570.58
Measbio1000 ccid50/0.5ml5The Biovac InstituteR1924.04

VACVaccine· 1 product

from R195.72
ProductStrengthPackApplicantMin price
Rouvax1000 tcid50/0.5ml0.5Sanofi Aventis South Africa (Pty) LtdR195.72

Medical aid coverage

data not yet integrated
Discovery Health
not yet integrated
  • Comprehensive Series—
  • Executive Plan—
  • KeyCare Series—
  • Priority Series—
  • Saver Series—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

Bonitas Medical Fund
not yet integrated
  • BonClassic—
  • BonComprehensive—
  • BonEssential—
  • BonFit Select—
  • BonSave—
  • BonStart—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

GEMS — Government Employees Medical Scheme
not yet integrated
  • Beryl—
  • Emerald—
  • Onyx—
  • Ruby—
  • Sapphire—
  • Tanzanite One—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

POLMED — Police Medical Aid Scheme
not yet integrated
  • Aquarium Option—
  • Efficiency Option—
  • Marine Option—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

NeoHealth® ID 16472 · updated 10/3/2024